aluates Reports

$ 0.0

Automative

Global Molecular Theranostics Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-4G14239

Global Molecular Theranostics Market Research Report 2023

BUY CHAPTERS

Global Molecular Theranostics Market Research Report 2025

Code: QYRE-Auto-4G14239

Report

May 2025

Pages:80

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Abbott

Biomerieux

Qiagen NV

Thermo Fisher Scientific

Agilent

GenMark

Siemens Healthcare

AutoGenomics

Molecular Theranostics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Molecular Theranostics Market

The global market for Molecular Theranostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Molecular theranostics can be described as a system that integrates a diagnostic test with a therapeutic intervention targeting a molecular feature of disease.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Molecular Theranostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Theranostics.

The Molecular Theranostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Molecular Theranostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Molecular Theranostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Molecular Theranostics Market Report

Report Metric	Details
Report Name	Molecular Theranostics Market
CAGR	5%
Segment by Type	Amplification Theranostics Amplified Gene Detection Theranostics Oligonucleotide Microarrays Gene Sequencing
Segment by Application	Hospitals and Clinics Research Institutes Diagnostic Centers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Abbott, BD, Biomerieux, Qiagen, Thermo Fisher Scientific, Agilent, GenMark, Siemens Healthcare, AutoGenomics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Theranostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Molecular Theranostics Market report?

Ans: The main players in the Molecular Theranostics Market are Roche, Abbott, BD, Biomerieux, Qiagen, Thermo Fisher Scientific, Agilent, GenMark, Siemens Healthcare, AutoGenomics

What are the Application segmentation covered in the Molecular Theranostics Market report?

Ans: The Applications covered in the Molecular Theranostics Market report are Hospitals and Clinics, Research Institutes, Diagnostic Centers, Others

What are the Type segmentation covered in the Molecular Theranostics Market report?

Ans: The Types covered in the Molecular Theranostics Market report are Amplification Theranostics, Amplified Gene Detection Theranostics, Oligonucleotide Microarrays, Gene Sequencing

Recommended Reports

Diagnostic Technologies

Cancer Therapeutics

Advanced Drug Delivery

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Molecular Theranostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Amplification Theranostics

1.2.3 Amplified Gene Detection Theranostics

1.2.4 Oligonucleotide Microarrays

1.2.5 Gene Sequencing

1.3 Market by Application

1.3.1 Global Molecular Theranostics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals and Clinics

1.3.3 Research Institutes

1.3.4 Diagnostic Centers

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Molecular Theranostics Market Perspective (2020-2031)

2.2 Global Molecular Theranostics Growth Trends by Region

2.2.1 Global Molecular Theranostics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Molecular Theranostics Historic Market Size by Region (2020-2025)

2.2.3 Molecular Theranostics Forecasted Market Size by Region (2026-2031)

2.3 Molecular Theranostics Market Dynamics

2.3.1 Molecular Theranostics Industry Trends

2.3.2 Molecular Theranostics Market Drivers

2.3.3 Molecular Theranostics Market Challenges

2.3.4 Molecular Theranostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Molecular Theranostics Players by Revenue

3.1.1 Global Top Molecular Theranostics Players by Revenue (2020-2025)

3.1.2 Global Molecular Theranostics Revenue Market Share by Players (2020-2025)

3.2 Global Molecular Theranostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Molecular Theranostics Revenue

3.4 Global Molecular Theranostics Market Concentration Ratio

3.4.1 Global Molecular Theranostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Molecular Theranostics Revenue in 2024

3.5 Global Key Players of Molecular Theranostics Head office and Area Served

3.6 Global Key Players of Molecular Theranostics, Product and Application

3.7 Global Key Players of Molecular Theranostics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Molecular Theranostics Breakdown Data by Type

4.1 Global Molecular Theranostics Historic Market Size by Type (2020-2025)

4.2 Global Molecular Theranostics Forecasted Market Size by Type (2026-2031)

5 Molecular Theranostics Breakdown Data by Application

5.1 Global Molecular Theranostics Historic Market Size by Application (2020-2025)

5.2 Global Molecular Theranostics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Molecular Theranostics Market Size (2020-2031)

6.2 North America Molecular Theranostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Molecular Theranostics Market Size by Country (2020-2025)

6.4 North America Molecular Theranostics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Molecular Theranostics Market Size (2020-2031)

7.2 Europe Molecular Theranostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Molecular Theranostics Market Size by Country (2020-2025)

7.4 Europe Molecular Theranostics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Molecular Theranostics Market Size (2020-2031)

8.2 Asia-Pacific Molecular Theranostics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Molecular Theranostics Market Size by Region (2020-2025)

8.4 Asia-Pacific Molecular Theranostics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Molecular Theranostics Market Size (2020-2031)

9.2 Latin America Molecular Theranostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Molecular Theranostics Market Size by Country (2020-2025)

9.4 Latin America Molecular Theranostics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Molecular Theranostics Market Size (2020-2031)

10.2 Middle East & Africa Molecular Theranostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Molecular Theranostics Market Size by Country (2020-2025)

10.4 Middle East & Africa Molecular Theranostics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Molecular Theranostics Introduction

11.1.4 Roche Revenue in Molecular Theranostics Business (2020-2025)

11.1.5 Roche Recent Development

11.2 Abbott

11.2.1 Abbott Company Details

11.2.2 Abbott Business Overview

11.2.3 Abbott Molecular Theranostics Introduction

11.2.4 Abbott Revenue in Molecular Theranostics Business (2020-2025)

11.2.5 Abbott Recent Development

11.3 BD

11.3.1 BD Company Details

11.3.2 BD Business Overview

11.3.3 BD Molecular Theranostics Introduction

11.3.4 BD Revenue in Molecular Theranostics Business (2020-2025)

11.3.5 BD Recent Development

11.4 Biomerieux

11.4.1 Biomerieux Company Details

11.4.2 Biomerieux Business Overview

11.4.3 Biomerieux Molecular Theranostics Introduction

11.4.4 Biomerieux Revenue in Molecular Theranostics Business (2020-2025)

11.4.5 Biomerieux Recent Development

11.5 Qiagen

11.5.1 Qiagen Company Details

11.5.2 Qiagen Business Overview

11.5.3 Qiagen Molecular Theranostics Introduction

11.5.4 Qiagen Revenue in Molecular Theranostics Business (2020-2025)

11.5.5 Qiagen Recent Development

11.6 Thermo Fisher Scientific

11.6.1 Thermo Fisher Scientific Company Details

11.6.2 Thermo Fisher Scientific Business Overview

11.6.3 Thermo Fisher Scientific Molecular Theranostics Introduction

11.6.4 Thermo Fisher Scientific Revenue in Molecular Theranostics Business (2020-2025)

11.6.5 Thermo Fisher Scientific Recent Development

11.7 Agilent

11.7.1 Agilent Company Details

11.7.2 Agilent Business Overview

11.7.3 Agilent Molecular Theranostics Introduction

11.7.4 Agilent Revenue in Molecular Theranostics Business (2020-2025)

11.7.5 Agilent Recent Development

11.8 GenMark

11.8.1 GenMark Company Details

11.8.2 GenMark Business Overview

11.8.3 GenMark Molecular Theranostics Introduction

11.8.4 GenMark Revenue in Molecular Theranostics Business (2020-2025)

11.8.5 GenMark Recent Development

11.9 Siemens Healthcare

11.9.1 Siemens Healthcare Company Details

11.9.2 Siemens Healthcare Business Overview

11.9.3 Siemens Healthcare Molecular Theranostics Introduction

11.9.4 Siemens Healthcare Revenue in Molecular Theranostics Business (2020-2025)

11.9.5 Siemens Healthcare Recent Development

11.10 AutoGenomics

11.10.1 AutoGenomics Company Details

11.10.2 AutoGenomics Business Overview

11.10.3 AutoGenomics Molecular Theranostics Introduction

11.10.4 AutoGenomics Revenue in Molecular Theranostics Business (2020-2025)

11.10.5 AutoGenomics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche

Abbott

Biomerieux

Qiagen NV

Thermo Fisher Scientific

Agilent

GenMark

Siemens Healthcare

AutoGenomics

List of Tables

Table 1. Global Molecular Theranostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Amplification Theranostics

Table 3. Key Players of Amplified Gene Detection Theranostics

Table 4. Key Players of Oligonucleotide Microarrays

Table 5. Key Players of Gene Sequencing

Table 6. Global Molecular Theranostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Molecular Theranostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Molecular Theranostics Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Molecular Theranostics Market Share by Region (2020-2025)

Table 10. Global Molecular Theranostics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Molecular Theranostics Market Share by Region (2026-2031)

Table 12. Molecular Theranostics Market Trends

Table 13. Molecular Theranostics Market Drivers

Table 14. Molecular Theranostics Market Challenges

Table 15. Molecular Theranostics Market Restraints

Table 16. Global Molecular Theranostics Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Molecular Theranostics Market Share by Players (2020-2025)

Table 18. Global Top Molecular Theranostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Theranostics as of 2024)

Table 19. Ranking of Global Top Molecular Theranostics Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Molecular Theranostics Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Molecular Theranostics, Headquarters and Area Served

Table 22. Global Key Players of Molecular Theranostics, Product and Application

Table 23. Global Key Players of Molecular Theranostics, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Molecular Theranostics Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Molecular Theranostics Revenue Market Share by Type (2020-2025)

Table 27. Global Molecular Theranostics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Molecular Theranostics Revenue Market Share by Type (2026-2031)

Table 29. Global Molecular Theranostics Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Molecular Theranostics Revenue Market Share by Application (2020-2025)

Table 31. Global Molecular Theranostics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Molecular Theranostics Revenue Market Share by Application (2026-2031)

Table 33. North America Molecular Theranostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Molecular Theranostics Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Molecular Theranostics Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Molecular Theranostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Molecular Theranostics Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Molecular Theranostics Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Molecular Theranostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Molecular Theranostics Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Molecular Theranostics Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Molecular Theranostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Molecular Theranostics Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Molecular Theranostics Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Molecular Theranostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Molecular Theranostics Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Molecular Theranostics Market Size by Country (2026-2031) & (US$ Million)

Table 48. Roche Company Details

Table 49. Roche Business Overview

Table 50. Roche Molecular Theranostics Product

Table 51. Roche Revenue in Molecular Theranostics Business (2020-2025) & (US$ Million)

Table 52. Roche Recent Development

Table 53. Abbott Company Details

Table 54. Abbott Business Overview

Table 55. Abbott Molecular Theranostics Product

Table 56. Abbott Revenue in Molecular Theranostics Business (2020-2025) & (US$ Million)

Table 57. Abbott Recent Development

Table 58. BD Company Details

Table 59. BD Business Overview

Table 60. BD Molecular Theranostics Product

Table 61. BD Revenue in Molecular Theranostics Business (2020-2025) & (US$ Million)

Table 62. BD Recent Development

Table 63. Biomerieux Company Details

Table 64. Biomerieux Business Overview

Table 65. Biomerieux Molecular Theranostics Product

Table 66. Biomerieux Revenue in Molecular Theranostics Business (2020-2025) & (US$ Million)

Table 67. Biomerieux Recent Development

Table 68. Qiagen Company Details

Table 69. Qiagen Business Overview

Table 70. Qiagen Molecular Theranostics Product

Table 71. Qiagen Revenue in Molecular Theranostics Business (2020-2025) & (US$ Million)

Table 72. Qiagen Recent Development

Table 73. Thermo Fisher Scientific Company Details

Table 74. Thermo Fisher Scientific Business Overview

Table 75. Thermo Fisher Scientific Molecular Theranostics Product

Table 76. Thermo Fisher Scientific Revenue in Molecular Theranostics Business (2020-2025) & (US$ Million)

Table 77. Thermo Fisher Scientific Recent Development

Table 78. Agilent Company Details

Table 79. Agilent Business Overview

Table 80. Agilent Molecular Theranostics Product

Table 81. Agilent Revenue in Molecular Theranostics Business (2020-2025) & (US$ Million)

Table 82. Agilent Recent Development

Table 83. GenMark Company Details

Table 84. GenMark Business Overview

Table 85. GenMark Molecular Theranostics Product

Table 86. GenMark Revenue in Molecular Theranostics Business (2020-2025) & (US$ Million)

Table 87. GenMark Recent Development

Table 88. Siemens Healthcare Company Details

Table 89. Siemens Healthcare Business Overview

Table 90. Siemens Healthcare Molecular Theranostics Product

Table 91. Siemens Healthcare Revenue in Molecular Theranostics Business (2020-2025) & (US$ Million)

Table 92. Siemens Healthcare Recent Development

Table 93. AutoGenomics Company Details

Table 94. AutoGenomics Business Overview

Table 95. AutoGenomics Molecular Theranostics Product

Table 96. AutoGenomics Revenue in Molecular Theranostics Business (2020-2025) & (US$ Million)

Table 97. AutoGenomics Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Molecular Theranostics Picture

Figure 2. Global Molecular Theranostics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Molecular Theranostics Market Share by Type: 2024 VS 2031

Figure 4. Amplification Theranostics Features

Figure 5. Amplified Gene Detection Theranostics Features

Figure 6. Oligonucleotide Microarrays Features

Figure 7. Gene Sequencing Features

Figure 8. Global Molecular Theranostics Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Molecular Theranostics Market Share by Application: 2024 VS 2031

Figure 10. Hospitals and Clinics Case Studies

Figure 11. Research Institutes Case Studies

Figure 12. Diagnostic Centers Case Studies

Figure 13. Others Case Studies

Figure 14. Molecular Theranostics Report Years Considered

Figure 15. Global Molecular Theranostics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Molecular Theranostics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Molecular Theranostics Market Share by Region: 2024 VS 2031

Figure 18. Global Molecular Theranostics Market Share by Players in 2024

Figure 19. Global Top Molecular Theranostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Theranostics as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Molecular Theranostics Revenue in 2024

Figure 21. North America Molecular Theranostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Molecular Theranostics Market Share by Country (2020-2031)

Figure 23. United States Molecular Theranostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Molecular Theranostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Molecular Theranostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Molecular Theranostics Market Share by Country (2020-2031)

Figure 27. Germany Molecular Theranostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Molecular Theranostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Molecular Theranostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Molecular Theranostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Molecular Theranostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Molecular Theranostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Molecular Theranostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Molecular Theranostics Market Share by Region (2020-2031)

Figure 35. China Molecular Theranostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Molecular Theranostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Molecular Theranostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Molecular Theranostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Molecular Theranostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Molecular Theranostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Molecular Theranostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Molecular Theranostics Market Share by Country (2020-2031)

Figure 43. Mexico Molecular Theranostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Molecular Theranostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Molecular Theranostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Molecular Theranostics Market Share by Country (2020-2031)

Figure 47. Turkey Molecular Theranostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Molecular Theranostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Molecular Theranostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Roche Revenue Growth Rate in Molecular Theranostics Business (2020-2025)

Figure 51. Abbott Revenue Growth Rate in Molecular Theranostics Business (2020-2025)

Figure 52. BD Revenue Growth Rate in Molecular Theranostics Business (2020-2025)

Figure 53. Biomerieux Revenue Growth Rate in Molecular Theranostics Business (2020-2025)

Figure 54. Qiagen Revenue Growth Rate in Molecular Theranostics Business (2020-2025)

Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Molecular Theranostics Business (2020-2025)

Figure 56. Agilent Revenue Growth Rate in Molecular Theranostics Business (2020-2025)

Figure 57. GenMark Revenue Growth Rate in Molecular Theranostics Business (2020-2025)

Figure 58. Siemens Healthcare Revenue Growth Rate in Molecular Theranostics Business (2020-2025)

Figure 59. AutoGenomics Revenue Growth Rate in Molecular Theranostics Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Molecular Diagnostic Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Molecular Diagnostic Platform Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Molecular Diagnostic Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oncology Based Molecular Diagnostics Market Insights Forecast to 2030

Global Molecular Imaging Device Market Research Report 2024

Oncology Based Molecular Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Precancer Molecular Diagnostics Market Research Report 2024

Global Breast Cancer Molecular Diagnostics Market Research Report 2024

Global Molecular Testing Service Market Research Report 2025

Global Molecular Diagnostic Kits Market Research Report 2025

Global Molecular Imager Market Research Report 2025

Molecular Diagnosis of Tumors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Molecular Diagnostics in Point of Care Market Research Report 2024

Medical Molecular Imaging System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Mobile Molecular Diagnostic System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Molecular Diagnostics Tests Reagents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Brain Cancer Molecular Diagnostics Market Research Report 2024

Global Melanoma Molecular Diagnostics Market Research Report 2024

Global Molecular Diagnostic Instrument Market Insights Forecast to 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions